I like that one of the authors of this US paper describing gene therapy to restore sight in sufferers from a rare form of blindness, itself a refinement of a treatment first given in the UK, is called “Elizabeth Windsor”:

“One of the patients said that the dim red light from his alarm clock had gotten so bright that it bothered him,” said Artur Cideciyan, a University of Pennsylvania opthamologist and co-author of the study. “He had to turn away from it while he was sleeping.”